FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20230617E00012
1. Date of relevant event: 16/06/2023
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 02190
4. Name of listed corporation: 歸創通橋醫療科技股份有限公司 - B - H股 
5. Class of shares: H Shares 
6. Number of issued shares in class: 332,401,001
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Wang
(Other names) Stephen Hui
10. Name of director (Chinese): 王晖 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1201The number of shares in which you are interested has reduced because:
you completed a sale of the shares
 
2201Interest of corporation controlled by you
 
2201Interest of corporation controlled by you
 		 415,614  HKD       
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position26,547,0927.99
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position26,131,4787.86
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2201Interest of corporation controlled by you
Long position26,131,478
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
苏州泰弘景晖投资中心（有限合伙）中国（江苏）自由贸易试验区苏州片区苏州工业园区苏虹中路225号星虹大厦1幢1801室C区042号（集群登记）王晖100.00N
Long position0
宁波保税区帖斯以股权投资合伙企业（有限合伙）浙江省宁波市北仑区新碶进港路406号2号楼15004-12室王晖100.00N
Long position2,927,696
Highlight Medical LimitedSuite 603, 6/F, Laws Commercial Plaza, 788 Cheung Sha Wan Road, Kowloon, Hong Kong王晖100.00N
Long position6,263,113
Five Investment LimitedSuite 603, 6/F, Laws Commercial Plaza, 788 Cheung Sha Wan Road, Kowloon, Hong Kong王晖100.00N
Long position9,227,691
Ourea Biotech HK LimitedUnit 3A, 12/F, Kaiser Centre, No. 18 Centre Street, Sai Ying Pun, Hong Kong王晖100.00N
Long position5,270,819
赣州提坦股权投资合伙企业（有限合伙）江西省赣州市章贡区新赣州大道18号阳明国际中心2号楼601-271室王晖100.00N
Long position1,306,810
Homehealth Investment LimitedSuite 603, 6/F, Laws Commercial Plaza, 788 Cheung Sha Wan Road, Kowloon, Hong Kong王晖100.00N
Long position1,135,349
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information:
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 17/06/2023
(dd/mm/yyyy)